Inventiva S.A. (EPA:IVA)
France flag France · Delayed Price · Currency is EUR
2.705
-0.030 (-1.10%)
Oct 19, 2026, 5:35 PM CET

Inventiva Revenue

Inventiva had revenue of 1.31M EUR in the half year ending June 30, 2026, a decrease of -52.23%. This brings the company's total for the last twelve months to 3.62M, down -75.47% year-over-year. In the year 2025, Inventiva had annual revenue of 7.93M, down -46.17%. That makes Inventiva the 41,655th largest company in the world by revenue and 557th in France.

Revenue (ttm)
3.62M
Revenue Growth
-75.47%
P/S Ratio
260.24
Revenue / Employee
28.23K
Employees
87
Market Cap
639.14M

Revenue Chart

Revenue by Geography

  • China 9.13M 99.2%
  • France 69.00K 0.8%
Fiscal year ended Dec 31, 2024 See the full Inventiva breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.93M-6.80M-46.17%
Dec 31, 202414.72M-8.44M-36.43%
Dec 31, 202323.16M4.35M23.12%
Dec 31, 202218.81M10.31M121.32%
Dec 31, 20218.50M3.24M61.52%
Dec 31, 20205.26M-6.03M-53.39%
Dec 31, 201911.29M3.91M53.02%
Dec 31, 20187.38M-2.58M-25.90%
Dec 31, 20179.96M-4.39M-30.61%
Dec 31, 201614.35M5.69M65.66%
Dec 31, 20158.66M2.36M37.55%
Dec 31, 20146.30M1.20M23.46%
Dec 31, 20135.10M5.06M10,977.18%
Dec 31, 201246.06K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE142.94M
Genfit59.49M
Cellectis55.86M
MedinCell24.28M
Nanobiotix11.51M
Innate Pharma9.81M
Sensorion6.16M
Transgene5.62M
Revenue Rankings